Amedeo Smart

Free Medical Literature Service

 

Amedeo

Chronic Heart Failure
  Free Subscription

Articles published in
J Mol Cell Cardiol
    September 2025
  1. CHEN D, Sindone A, Huang MLH, Peter K, et al
    Diabetic cardiomyopathy: insights into pathophysiology, diagnosis and clinical management.
    J Mol Cell Cardiol. 2025;206:55-69.
    >> Share

    April 2025
  2. SPAGNOL G, Trease A, Zheng L, Sobota S, et al
    Cx45 regulation by kinases and impact of expression in heart failure.
    J Mol Cell Cardiol. 2025;203:91-105.
    >> Share

  3. MCLENDON JM, Zhang X, Stein CS, Baehr LM, et al
    Gain and loss of the centrosomal protein taxilin-beta influences cardiac proteostasis and stress.
    J Mol Cell Cardiol. 2025;201:56-69.
    >> Share

  4. SMOLGOVSKY S, Bayer AL, Aronovitz M, Vanni KMM, et al
    Experimental pressure overload induces a cardiac neoantigen specific humoral immune response.
    J Mol Cell Cardiol. 2025;201:87-93.
    >> Share

    March 2025
  5. ROBERTS TD, Hutchinson DS, Wootten D, De Blasio MJ, et al
    Advances in incretin therapies for targeting cardiovascular disease in diabetes.
    J Mol Cell Cardiol. 2025;202:102-115.
    >> Share

  6. CHEN Z, Zhong M, Lin Y, Zhang W, et al
    METTL7B-induced histone lactylation prevents heart failure by ameliorating cardiac remodelling.
    J Mol Cell Cardiol. 2025 Mar 9:S0022-2828(25)00046.
    >> Share

    February 2025
  7. GUAN J, Fefelova N, Zhai P, Ikeda Y, et al
    Dual inhibition of Mst1 and Mst2 exacerbates cardiac dysfunction during pressure overload stress in mice.
    J Mol Cell Cardiol. 2025;199:133-136.
    >> Share

    January 2025
  8. SHABANI P, Dong F, Yun J, Shin SY, et al
    Does coronary microvascular dysfunction play a role in heart failure with reduced ejection fraction?
    J Mol Cell Cardiol. 2025 Jan 28:S0022-2828(25)00007.
    >> Share

    December 2024
  9. KASS DA
    Assessing and interpreting diastolic function in animal models of heart disease.
    J Mol Cell Cardiol. 2024;197:1-4.
    >> Share

    November 2024
  10. KATTIH B, Fischer A, Muhly-Reinholz M, Tombor L, et al
    Inhibition of miR-92a normalizes vascular gene expression and prevents diastolic dysfunction in heart failure with preserved ejection fraction.
    J Mol Cell Cardiol. 2024 Nov 24:S0022-2828(24)00194.
    >> Share

  11. FU J, Li L, Chen L, Su C, et al
    Corrigendum to "PGE2 protects against heart failure through inhibiting TGF-beta1 synthesis in cardiomyocytes and crosstalk between TGF-beta1 and GRK2" [Journal of Molecular and Cellular Cardiology. 172(2022) 63-77].
    J Mol Cell Cardiol. 2024 Nov 22:S0022-2828(24)00191.
    >> Share

  12. ABBAS N, Bentele M, Waleczek FJG, Fuchs M, et al
    Ex vivo modelling of cardiac injury identifies ferroptosis-related pathways as a potential therapeutic avenue for translational medicine.
    J Mol Cell Cardiol. 2024;196:125-140.
    >> Share

  13. ZERVOU S, McAndrew DJ, Lake HA, Kuznecova E, et al
    Cardiac function and energetics in mice with combined genetic augmentation of creatine and creatine kinase activity.
    J Mol Cell Cardiol. 2024;196:105-114.
    >> Share

    October 2024
  14. JANI VP, Koleini N, Fenwick AJ, Sharp TE, et al
    Cardiomyocyte myofilament function in common animal models of heart failure with preserved ejection fraction.
    J Mol Cell Cardiol. 2024 Oct 18:S0022-2828(24)00166.
    >> Share

  15. BEITO M, Taegtmeyer H
    Metabolic cycles: A unifying concept for energy transfer in the heart.
    J Mol Cell Cardiol. 2024;195:103-109.
    >> Share

  16. FAN D, Wu R
    Mechanisms of the septic heart: From inflammatory response to myocardial edema.
    J Mol Cell Cardiol. 2024;195:73-82.
    >> Share

  17. KAPLAN AD, Boyman L, Ward CW, Lederer WJ, et al
    Ryanodine receptor stabilization therapy suppresses Ca(2+)- based arrhythmias in a novel model of metabolic HFpEF.
    J Mol Cell Cardiol. 2024;195:68-72.
    >> Share

    August 2024
  18. WALKER MA, Tian R
    NAD metabolism and heart failure: Mechanisms and therapeutic potentials.
    J Mol Cell Cardiol. 2024;195:45-54.
    >> Share

    July 2024
  19. CANTRELL AC, Besanson J, Williams Q, Hoang N, et al
    Ferrostatin-1 specifically targets mitochondrial iron-sulfur clusters and aconitase to improve cardiac function in Sirtuin 3 cardiomyocyte knockout mice.
    J Mol Cell Cardiol. 2024;192:36-47.
    >> Share

  20. LAHIRI SK, Lu J, Aguilar-Sanchez Y, Li H, et al
    Targeting Calpain-2-mediated Junctophilin-2 cleavage delays heart failure progression following myocardial infarction.
    J Mol Cell Cardiol. 2024 Jul 1:S0022-2828(24)00108.
    >> Share

    April 2024
  21. CHOKSEY A, Carter RD, Thackray BD, Ball V, et al
    AICAR confers prophylactic cardioprotection in doxorubicin-induced heart failure in rats.
    J Mol Cell Cardiol. 2024;191:12-22.
    >> Share

    March 2024
  22. NGUYEN T, Rosa-Garrido M, Sadek H, Garry DJ, et al
    Promoting cardiomyocyte proliferation for myocardial regeneration in large mammals.
    J Mol Cell Cardiol. 2024;188:52-60.
    >> Share

    February 2024
  23. ANTIPENKO S, Mayfield N, Jinno M, Gunzer M, et al
    Neutrophils are indispensable for adverse cardiac remodeling in heart failure.
    J Mol Cell Cardiol. 2024;189:1-11.
    >> Share

  24. SOMA Y, Tani H, Morita-Umei Y, Kishino Y, et al
    Pluripotent stem cell-based cardiac regenerative therapy for heart failure.
    J Mol Cell Cardiol. 2024;187:90-100.
    >> Share

  25. SAKAMOTO T, Kelly DP
    Cardiac maturation.
    J Mol Cell Cardiol. 2024;187:38-50.
    >> Share

    January 2024
  26. SHI L, Li X, Zhang M, Qin C, et al
    Downregulation of Wtap causes dilated cardiomyopathy and heart failure.
    J Mol Cell Cardiol. 2024 Jan 13:S0022-2828(24)00002.
    >> Share

  27. SHINTANI Y, Fukushima S, Varela-Carver A, Lee J, et al
    Corrigendum to "Donor cell-type specific paracrine effects of cell transplantation for post-infarction heart failure" [J Mol Cell Cardiol 47 (2009) 288-295].
    J Mol Cell Cardiol. 2024 Jan 10:S0022-2828(24)00001.
    >> Share

  28. CHU Y, Hua Y, He L, He J, et al
    beta-hydroxybutyrate administered at reperfusion reduces infarct size and preserves cardiac function by improving mitochondrial function through autophagy in male mice.
    J Mol Cell Cardiol. 2024;186:31-44.
    >> Share

    November 2023
  29. MANGIONE MC, Wen J, Cao DJ
    Mechanistic target of rapamycin in regulating macrophage function in inflammatory cardiovascular diseases.
    J Mol Cell Cardiol. 2023;186:111-124.
    >> Share

  30. CHEN S, Wang K, Wang J, Chen X, et al
    Profiling cardiomyocytes at single cell resolution reveals COX7B could be a potential target for attenuating heart failure in cardiac hypertrophy.
    J Mol Cell Cardiol. 2023;186:45-56.
    >> Share

    October 2023
  31. WADDELL HMM, Mereacre V, Alvarado FJ, Munro ML, et al
    Clustering properties of the cardiac ryanodine receptor in health and heart failure.
    J Mol Cell Cardiol. 2023;185:38-49.
    >> Share

  32. ZHAO C, Jiang X, Peng L, Zhang Y, et al
    Glimepiride, a novel soluble epoxide hydrolase inhibitor, protects against heart failure via increasing epoxyeicosatrienoic acids.
    J Mol Cell Cardiol. 2023;185:13-25.
    >> Share

  33. MENASCHE P
    Human PSC-derived cardiac cells and their products: therapies for cardiac repair.
    J Mol Cell Cardiol. 2023;183:14-21.
    >> Share

    September 2023
  34. LIU Z, Liu Z, Xu X, Zhou Y, et al
    Role of ventrolateral part of ventromedial hypothalamus in post-myocardial infarction cardiac dysfunction induced by sympathetic nervous system.
    J Mol Cell Cardiol. 2023 Sep 30:S0022-2828(23)00154.
    >> Share

  35. PEZHOUMAN A, Nguyen NB, Kay M, Kanjilal B, et al
    Cardiac regeneration - Past advancements, current challenges, and future directions.
    J Mol Cell Cardiol. 2023;182:75-85.
    >> Share

    August 2023
  36. KMIETCZYK V, Oelschlager J, Gupta P, Varma E, et al
    Ythdf2 regulates cardiac remodeling through its mRNA target transcripts.
    J Mol Cell Cardiol. 2023;181:57-66.
    >> Share

    July 2023
  37. KOBAYASHI S, Yamamoto T, Yano M
    RyR2-stabilization therapy with dantrolene against left ventricular remodeling and lethal arrhythmia in heart failure.
    J Mol Cell Cardiol. 2023 Jul 5:S0022-2828(23)00108.
    >> Share

    June 2023
  38. MONTANES-AGUDO P, Pinto YM, Creemers EE
    Splicing factors in the heart: Uncovering shared and unique targets.
    J Mol Cell Cardiol. 2023;179:72-79.
    >> Share

    May 2023
  39. YAMADA Y, Sadahiro T, Ieda M
    Development of direct cardiac reprogramming for clinical applications.
    J Mol Cell Cardiol. 2023;178:1-8.
    >> Share

    April 2023
  40. MEHDIPOUR M, Park S, Huang GN
    Unlocking cardiomyocyte renewal potential for myocardial regeneration therapy.
    J Mol Cell Cardiol. 2023;177:9-20.
    >> Share

  41. LI R, Xiang C, Li Y, Nie Y, et al
    Targeting immunoregulation for cardiac regeneration.
    J Mol Cell Cardiol. 2023;177:1-8.
    >> Share

    March 2023
  42. GARRY GA, Olson EN
    Reprogramming of cardiac cell fate as a therapeutic strategy for ischemic heart disease.
    J Mol Cell Cardiol. 2023 Mar 28:S0022-2828(23)00058.
    >> Share

  43. FUJII S, Kobayashi S, Chang Y, Nawata J, et al
    RyR2-targeting therapy prevents left ventricular remodeling and ventricular tachycardia in post-infarction heart failure.
    J Mol Cell Cardiol. 2023 Mar 22:S0022-2828(23)00052.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016